首页> 外文期刊>AIDS Research and Human Retroviruses >Optimized Replicating Renilla Luciferase Reporter HIV-1 Utilizing Novel Internal Ribosome Entry Site Elements for Native Nef Expression and Function
【24h】

Optimized Replicating Renilla Luciferase Reporter HIV-1 Utilizing Novel Internal Ribosome Entry Site Elements for Native Nef Expression and Function

机译:优化的复制海肾荧光素酶记者HIV-1利用新型内部核糖体进入位点元素的天然Nef表达和功能。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We previously developed replication-competent reporter HIV-1 (referred to herein as LucR.T2A reporter viruses), utilizing a ribosome skipping T2A peptide strategy to link Renilla luciferase (LucR) with Nef expression. The demonstrated utility for HIV-1 vaccine and transmission study applications included measurement of neutralizing antibody (NAb) activity in vaccine sera, improved cell-mediated virus inhibition assays, such as T cell-mediated virus inhibition and antibody-dependent cell-mediated cytotoxicity (ADCC) assays, and humanized mouse models. Herein, we extend our prior work and introduce reporter virus technology for applications that require fully functional Nef. We demonstrate that in CD4(+) T cells productively infected with LucR.T2A reporter viruses, T2A peptide-driven Nef expression and function, such as down-regulation of surface CD4 and MHC-I, were impaired. We overcame this limitation of LucR.T2A reporter viruses and achieved physiological Nef expression and function by engineering novel LucR reporter HIV-1 comprising 11 different internal ribosome entry site (IRES) elements chosen for size and relative activity. A range of Nef expression was observed in 293T cells transfected with the different LucR.IRES reporter virus constructs. Iteratively, we identified IRES reporter genomes that expressed Nef closest to physiological levels and produced virus with infectivity, titers, and replication kinetics similar to nonreporter viruses. Our results demonstrated that LucR reporter activity was stable over multiple replication cycles in peripheral blood mononuclear cells (PBMCs). Furthermore, we analyzed Nef functionality, i.e., down-modulation of MHC-I and CD4, following infection of T cell lines and PBMCs. Unlike LucR.T2A reporter virus, one of the redesigned LucR.IRES reporter viruses [containing the modified encephalomyocarditis virus (EMCV) 6ATR IRES element, 6ATRi] demonstrated Nef expression and function similar to parental nonreporter virus. In a previously validated (nef-independent) T cell-based NAb neutralization assay, LucR.6ATRi reporter virus performed indistinguishably from LucR.T2A reporter virus. In summary, reporter viruses comprising the 6ATRi element promise to augment HIV-1 vaccine and transmission research approaches requiring a sensitive reporter readout combined with wild-type Nef function.
机译:我们先前利用核糖体跳过T2A肽策略将海肾荧光素酶(LucR)与Nef表达连接,开发了具有复制能力的报道基因HIV-1(在本文中称为LucR.T2A报道病毒)。已证明可用于HIV-1疫苗和传播研究的实用程序包括测量疫苗血清中的中和抗体(NAb)活性,改进的细胞介导的病毒抑制测定法,例如T细胞介导的病毒抑制和抗体依赖性细胞介导的细胞毒性( ADCC)分析和人性化的小鼠模型。在此,我们扩展了先前的工作,并针对需要全功能Nef的应用程序引入了报告病毒技术。我们证明在生产性感染LucR.T2A报道病毒的CD4(+)T细胞中,T2A肽驱动的Nef表达和功能(如表面CD4和MHC-1的下调)受到损害。我们克服了LucR.T2A报告基因病毒的这一局限性,并通过工程改造新颖的LucR报告基因HIV-1来实现生理Nef表达和功能,其中包括11种不同的内部核糖体进入位点(IRES)元素,这些元素是根据大小和相对活性选择的。在用不同的LucR.IRES报告基因病毒转染的293T细胞中观察到了一系列Nef表达。反复地,我们确定了IRES报告基因组,其表达的Nef最接近生理水平,并产生了具有与非报告病毒相似的感染性,滴度和复制动力学的病毒。我们的结果表明,LucR报告基因活性在外周血单个核细胞(PBMC)的多个复制周期中稳定。此外,我们分析了Nef功能,即在T细胞系和PBMC感染后,MHC-1和CD4的下调。与LucR.T2A报告病毒不同,经过重新设计的LucR.IRES报告病毒之一[包含修饰的脑心肌炎病毒(EMCV)6ATR IRES元素6ATRi]表现出Nef的表达和功能类似于亲本非报告病毒。在先前验证的(独立于Nef的)T细胞NAb中和测定中,LucR.6ATRi报告病毒与LucR.T2A报告病毒没有区别。总之,包含6ATRi元素的报告病毒有望增加HIV-1疫苗和传播研究方法,需要敏感的报告读数与野生型Nef功能相结合。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号